1 Parkinson's Disease (PD) Drugs Market Overview 1.1 Parkinson's Disease (PD) Drugs Product Scope 1.2 Parkinson's Disease (PD) Drugs Segment by Type 1.2.1 Global Parkinson's Disease (PD) Drugs Sales by Type (2016 & 2021 & 2027) 1.2.2 Dopamine Agonist 1.2.3 Monoamine Oxidase Inhibitors 1.2.4 Acetylcholinesterase Inhibitors 1.2.5 Glutamate Inhibitors 1.3 Parkinson's Disease (PD) Drugs Segment by Application 1.3.1 Global Parkinson's Disease (PD) Drugs Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Hospital 1.3.3 Family 1.4 Parkinson's Disease (PD) Drugs Market Estimates and Forecasts (2016-2027) 1.4.1 Global Parkinson's Disease (PD) Drugs Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Parkinson's Disease (PD) Drugs Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Parkinson's Disease (PD) Drugs Price Trends (2016-2027) 2 Parkinson's Disease (PD) Drugs Estimates and Forecasts by Region 2.1 Global Parkinson's Disease (PD) Drugs Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021) 2.2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021) 2.3 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027) 2.4.2 Europe Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027) 2.4.3 China Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027) 2.4.4 Japan Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027) 2.4.6 India Parkinson's Disease (PD) Drugs Estimates and Projections (2016-2027) 3 Global Parkinson's Disease (PD) Drugs Competition Landscape by Players 3.1 Global Top Parkinson's Disease (PD) Drugs Players by Sales (2016-2021) 3.2 Global Top Parkinson's Disease (PD) Drugs Players by Revenue (2016-2021) 3.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2020) 3.4 Global Parkinson's Disease (PD) Drugs Average Price by Company (2016-2021) 3.5 Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Parkinson's Disease (PD) Drugs Market Size by Type 4.1 Global Parkinson's Disease (PD) Drugs Historic Market Review by Type (2016-2021) 4.1.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021) 4.1.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2016-2021) 4.1.3 Global Parkinson's Disease (PD) Drugs Price by Type (2016-2021) 4.2 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2022-2027) 5 Global Parkinson's Disease (PD) Drugs Market Size by Application 5.1 Global Parkinson's Disease (PD) Drugs Historic Market Review by Application (2016-2021) 5.1.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021) 5.1.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2016-2021) 5.1.3 Global Parkinson's Disease (PD) Drugs Price by Application (2016-2021) 5.2 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Parkinson's Disease (PD) Drugs Price Forecast by Application (2022-2027) 6 North America Parkinson's Disease (PD) Drugs Market Facts & Figures 6.1 North America Parkinson's Disease (PD) Drugs Sales by Company 6.1.1 North America Parkinson's Disease (PD) Drugs Sales by Company (2016-2021) 6.1.2 North America Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) 6.2 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Type 6.2.1 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021) 6.2.2 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027) 6.3 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Application 6.3.1 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2016-2021) 6.3.2 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2022-2027) 7 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures 7.1 Europe Parkinson's Disease (PD) Drugs Sales by Company 7.1.1 Europe Parkinson's Disease (PD) Drugs Sales by Company (2016-2021) 7.1.2 Europe Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) 7.2 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Type 7.2.1 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021) 7.2.2 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027) 7.3 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Application 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027) 8 China Parkinson's Disease (PD) Drugs Market Facts & Figures 8.1 China Parkinson's Disease (PD) Drugs Sales by Company 8.1.1 China Parkinson's Disease (PD) Drugs Sales by Company (2016-2021) 8.1.2 China Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) 8.2 China Parkinson's Disease (PD) Drugs Sales Breakdown by Type 8.2.1 China Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021) 8.2.2 China Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027) 8.3 China Parkinson's Disease (PD) Drugs Sales Breakdown by Application 8.3.1 China 167 Sales Breakdown by Application (2016-2021) 8.3.2 China 167 Sales Breakdown by Application (2022-2027) 9 Japan Parkinson's Disease (PD) Drugs Market Facts & Figures 9.1 Japan Parkinson's Disease (PD) Drugs Sales by Company 9.1.1 Japan Parkinson's Disease (PD) Drugs Sales by Company (2016-2021) 9.1.2 Japan Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) 9.2 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Type 9.2.1 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021) 9.2.2 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027) 9.3 Japan Parkinson's Disease (PD) Drugs Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Parkinson's Disease (PD) Drugs Market Facts & Figures 10.1 Southeast Asia Parkinson's Disease (PD) Drugs Sales by Company 10.1.1 Southeast Asia Parkinson's Disease (PD) Drugs Sales by Company (2016-2021) 10.1.2 Southeast Asia Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) 10.2 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Type 10.2.1 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Parkinson's Disease (PD) Drugs Sales Breakdown by Application 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027) 11 India Parkinson's Disease (PD) Drugs Market Facts & Figures 11.1 India Parkinson's Disease (PD) Drugs Sales by Company 11.1.1 India Parkinson's Disease (PD) Drugs Sales by Company (2016-2021) 11.1.2 India Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) 11.2 India Parkinson's Disease (PD) Drugs Sales Breakdown by Type 11.2.1 India Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2016-2021) 11.2.2 India Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2022-2027) 11.3 India Parkinson's Disease (PD) Drugs Sales Breakdown by Application 11.3.1 India Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2016-2021) 11.3.2 India Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Parkinson's Disease (PD) Drugs Business 12.1 Boehringer Ingelheim 12.1.1 Boehringer Ingelheim Corporation Information 12.1.2 Boehringer Ingelheim Business Overview 12.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered 12.1.5 Boehringer Ingelheim Recent Development 12.2 GlaxoSmithKline 12.2.1 GlaxoSmithKline Corporation Information 12.2.2 GlaxoSmithKline Business Overview 12.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered 12.2.5 GlaxoSmithKline Recent Development 12.3 Novartis 12.3.1 Novartis Corporation Information 12.3.2 Novartis Business Overview 12.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered 12.3.5 Novartis Recent Development 12.4 Teva Pharmaceutical Industries 12.4.1 Teva Pharmaceutical Industries Corporation Information 12.4.2 Teva Pharmaceutical Industries Business Overview 12.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered 12.4.5 Teva Pharmaceutical Industries Recent Development 12.5 AbbVie 12.5.1 AbbVie Corporation Information 12.5.2 AbbVie Business Overview 12.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered 12.5.5 AbbVie Recent Development 12.6 Abital Pharma 12.6.1 Abital Pharma Corporation Information 12.6.2 Abital Pharma Business Overview 12.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered 12.6.5 Abital Pharma Recent Development 12.7 Addex Therapeutics 12.7.1 Addex Therapeutics Corporation Information 12.7.2 Addex Therapeutics Business Overview 12.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered 12.7.5 Addex Therapeutics Recent Development 12.8 Biogen 12.8.1 Biogen Corporation Information 12.8.2 Biogen Business Overview 12.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered 12.8.5 Biogen Recent Development 12.9 Eisai 12.9.1 Eisai Corporation Information 12.9.2 Eisai Business Overview 12.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered 12.9.5 Eisai Recent Development 12.10 Eli Lilly 12.10.1 Eli Lilly Corporation Information 12.10.2 Eli Lilly Business Overview 12.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered 12.10.5 Eli Lilly Recent Development 12.11 F. Hoffmann-La Roche 12.11.1 F. Hoffmann-La Roche Corporation Information 12.11.2 F. Hoffmann-La Roche Business Overview 12.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Products Offered 12.11.5 F. Hoffmann-La Roche Recent Development 12.12 H. Lundbeck 12.12.1 H. Lundbeck Corporation Information 12.12.2 H. Lundbeck Business Overview 12.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Products Offered 12.12.5 H. Lundbeck Recent Development 12.13 Impax Laboratories 12.13.1 Impax Laboratories Corporation Information 12.13.2 Impax Laboratories Business Overview 12.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Products Offered 12.13.5 Impax Laboratories Recent Development 12.14 Kyowa Hakko Kirin 12.14.1 Kyowa Hakko Kirin Corporation Information 12.14.2 Kyowa Hakko Kirin Business Overview 12.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Products Offered 12.14.5 Kyowa Hakko Kirin Recent Development 12.15 Otsuka Pharmaceutical 12.15.1 Otsuka Pharmaceutical Corporation Information 12.15.2 Otsuka Pharmaceutical Business Overview 12.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Products Offered 12.15.5 Otsuka Pharmaceutical Recent Development 12.16 Pfizer 12.16.1 Pfizer Corporation Information 12.16.2 Pfizer Business Overview 12.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Pfizer Parkinson's Disease (PD) Drugs Products Offered 12.16.5 Pfizer Recent Development 13 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis 13.1 Parkinson's Disease (PD) Drugs Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs 13.4 Parkinson's Disease (PD) Drugs Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Parkinson's Disease (PD) Drugs Distributors List 14.3 Parkinson's Disease (PD) Drugs Customers 15 Market Dynamics 15.1 Parkinson's Disease (PD) Drugs Market Trends 15.2 Parkinson's Disease (PD) Drugs Drivers 15.3 Parkinson's Disease (PD) Drugs Market Challenges 15.4 Parkinson's Disease (PD) Drugs Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Parkinson's Disease (PD) Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Parkinson's Disease (PD) Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Parkinson's Disease (PD) Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Region (2016-2021) Table 5. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021) Table 6. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Parkinson's Disease (PD) Drugs Revenue Share by Region (2016-2021) Table 8. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Forecast by Region (2022-2027) Table 9. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Region (2022-2027) Table 10. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Parkinson's Disease (PD) Drugs Revenue Share Forecast by Region (2022-2027) Table 12. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) of Key Companies (2016-2021) Table 13. Global Parkinson's Disease (PD) Drugs Sales Share by Company (2016-2021) Table 14. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Company (2016-2021) Table 15. Global Parkinson's Disease (PD) Drugs Revenue Share by Company (2016-2021) Table 16. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2020) Table 17. Global Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) of Key Company (2016-2021) Table 18. Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites and Area Served Table 19. Manufacturers Parkinson's Disease (PD) Drugs Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2016-2021) Table 22. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021) Table 23. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2016-2021) Table 25. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2022-2027) Table 26. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2022-2027) Table 28. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2022-2027) Table 29. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2016-2021) Table 30. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021) Table 31. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2016-2021) Table 33. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2022-2027) Table 34. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2022-2027) Table 35. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2022-2027) Table 37. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2022-2027) Table 38. North America Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021) Table 39. North America Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021) Table 40. North America Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021) Table 42. North America Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs) Table 43. North America Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021) Table 44. North America Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs) Table 45. North America Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027) Table 46. North America Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs) Table 47. North America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021) Table 48. North America Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs) Table 49. North America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027) Table 50. Europe Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021) Table 51. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021) Table 52. Europe Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021) Table 54. Europe Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs) Table 55. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021) Table 56. Europe Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs) Table 57. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027) Table 58. Europe Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs) Table 59. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021) Table 60. Europe Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs) Table 61. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027) Table 62. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021) Table 63. China Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021) Table 64. China Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million) Table 65. China Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021) Table 66. China Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs) Table 67. China Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021) Table 68. China Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs) Table 69. China Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027) Table 70. China Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs) Table 71. China Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021) Table 72. China Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs) Table 73. China Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027) Table 74. Japan Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021) Table 75. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021) Table 76. Japan Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021) Table 78. Japan Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs) Table 79. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021) Table 80. Japan Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs) Table 81. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027) Table 82. Japan Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs) Table 83. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021) Table 84. Japan Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs) Table 85. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021) Table 87. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs) Table 91. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs) Table 93. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs) Table 95. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs) Table 97. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027) Table 98. India Parkinson's Disease (PD) Drugs Sales (K Pcs) by Company (2016-2021) Table 99. India Parkinson's Disease (PD) Drugs Sales Market Share by Company (2016-2021) Table 100. India Parkinson's Disease (PD) Drugs Revenue by Company (2016-2021) & (US$ Million) Table 101. India Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2016-2021) Table 102. India Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) & (K Pcs) Table 103. India Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021) Table 104. India Parkinson's Disease (PD) Drugs Sales by Type (2022-2027) & (K Pcs) Table 105. India Parkinson's Disease (PD) Drugs Sales Market Share by Type (2022-2027) Table 106. India Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) & (K Pcs) Table 107. India Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021) Table 108. India Parkinson's Disease (PD) Drugs Sales by Application (2022-2027) & (K Pcs) Table 109. India Parkinson's Disease (PD) Drugs Sales Market Share by Application (2022-2027) Table 110. Boehringer Ingelheim Corporation Information Table 111. Boehringer Ingelheim Description and Business Overview Table 112. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 113. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Table 114. Boehringer Ingelheim Recent Development Table 115. GlaxoSmithKline Corporation Information Table 116. GlaxoSmithKline Description and Business Overview Table 117. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Table 119. GlaxoSmithKline Recent Development Table 120. Novartis Corporation Information Table 121. Novartis Description and Business Overview Table 122. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 123. Novartis Parkinson's Disease (PD) Drugs Product Table 124. Novartis Recent Development Table 125. Teva Pharmaceutical Industries Corporation Information Table 126. Teva Pharmaceutical Industries Description and Business Overview Table 127. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 128. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Table 129. Teva Pharmaceutical Industries Recent Development Table 130. AbbVie Corporation Information Table 131. AbbVie Description and Business Overview Table 132. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 133. AbbVie Parkinson's Disease (PD) Drugs Product Table 134. AbbVie Recent Development Table 135. Abital Pharma Corporation Information Table 136. Abital Pharma Description and Business Overview Table 137. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 138. Abital Pharma Parkinson's Disease (PD) Drugs Product Table 139. Abital Pharma Recent Development Table 140. Addex Therapeutics Corporation Information Table 141. Addex Therapeutics Description and Business Overview Table 142. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 143. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Table 144. Addex Therapeutics Recent Development Table 145. Biogen Corporation Information Table 146. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 147. Biogen Description and Business Overview Table 148. Biogen Parkinson's Disease (PD) Drugs Product Table 149. Biogen Recent Development Table 150. Eisai Corporation Information Table 151. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 152. Eisai Description and Business Overview Table 153. Eisai Parkinson's Disease (PD) Drugs Product Table 154. Eisai Recent Development Table 155. Eli Lilly Corporation Information Table 156. Eli Lilly Description and Business Overview Table 157. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 158. Eli Lilly Parkinson's Disease (PD) Drugs Product Table 159. Eli Lilly Recent Development Table 160. F. Hoffmann-La Roche Corporation Information Table 161. F. Hoffmann-La Roche Description and Business Overview Table 162. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 163. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Table 164. F. Hoffmann-La Roche Recent Development Table 165. H. Lundbeck Corporation Information Table 166. H. Lundbeck Description and Business Overview Table 167. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 168. H. Lundbeck Parkinson's Disease (PD) Drugs Product Table 169. H. Lundbeck Recent Development Table 170. Impax Laboratories Corporation Information Table 171. Impax Laboratories Description and Business Overview Table 172. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 173. Impax Laboratories Parkinson's Disease (PD) Drugs Product Table 174. Impax Laboratories Recent Development Table 175. Kyowa Hakko Kirin Corporation Information Table 176. Kyowa Hakko Kirin Description and Business Overview Table 177. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 178. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Table 179. Kyowa Hakko Kirin Recent Development Table 180. Otsuka Pharmaceutical Corporation Information Table 181. Otsuka Pharmaceutical Description and Business Overview Table 182. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 183. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Table 184. Otsuka Pharmaceutical Recent Development Table 185. Pfizer Corporation Information Table 186. Pfizer Description and Business Overview Table 187. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 188. Pfizer Parkinson's Disease (PD) Drugs Product Table 189. Pfizer Recent Development Table 190. Production Base and Market Concentration Rate of Raw Material Table 191. Key Suppliers of Raw Materials Table 192. Parkinson's Disease (PD) Drugs Distributors List Table 193. Parkinson's Disease (PD) Drugs Customers List Table 194. Parkinson's Disease (PD) Drugs Market Trends Table 195. Parkinson's Disease (PD) Drugs Market Drivers Table 196. Parkinson's Disease (PD) Drugs Market Challenges Table 197. Parkinson's Disease (PD) Drugs Market Restraints Table 198. Research Programs/Design for This Report Table 199. Key Data Information from Secondary Sources Table 200. Key Data Information from Primary Sources List of Figures Figure 1. Parkinson's Disease (PD) Drugs Product Picture Figure 2. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2021 & 2027 Figure 3. Dopamine Agonist Product Picture Figure 4. Monoamine Oxidase Inhibitors Product Picture Figure 5. Acetylcholinesterase Inhibitors Product Picture Figure 6. Glutamate Inhibitors Product Picture Figure 7. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2021 & 2027 Figure 8. Hospital Examples Figure 9. Family Examples Figure 10. Global Parkinson's Disease (PD) Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Parkinson's Disease (PD) Drugs Sales Growth Rate (2016-2027) & (US$ Million) Figure 12. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Growth Rate (2016-2027) Figure 13. Global Parkinson's Disease (PD) Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs) Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region: 2016 VS 2021 Figure 15. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region: 2021 VS 2027 Figure 16. North America Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 17. North America Parkinson's Disease (PD) Drugs Sales (K Pcs) Growth Rate (2016-2027) Figure 18. Europe Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 19. Europe Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 20. China Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 21. China Parkinson's Disease (PD) Drugs Sales (Million USD) and Growth Rate (2016-2027) Figure 22. Japan Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Japan Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 25. Southeast Asia Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 26. India Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 27. India Parkinson's Disease (PD) Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 28. Global 5 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue in Parkinson's Disease (PD) Drugs: 2016 & 2020 Figure 29. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 30. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2016-2021) Figure 31. Global Parkinson's Disease (PD) Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 32. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2016-2021) Figure 33. Global Parkinson's Disease (PD) Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 34. North America Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 Figure 35. North America Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 Figure 36. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 Figure 37. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 Figure 38. China Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 Figure 39. China Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 Figure 40. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 Figure 41. Japan Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 Figure 42. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 Figure 43. Southeast Asia Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 Figure 44. India Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 Figure 45. India Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 Figure 46. Key Raw Materials Price Trend Figure 47. Manufacturing Cost Structure of Parkinson's Disease (PD) Drugs Figure 48. Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs Figure 49. Parkinson's Disease (PD) Drugs Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Boehringer Ingelheim GlaxoSmithKline Novartis Teva Pharmaceutical Industries AbbVie Abital Pharma Addex Therapeutics Biogen Eisai Eli Lilly F. Hoffmann-La Roche H. Lundbeck Impax Laboratories Kyowa Hakko Kirin Otsuka Pharmaceutical Pfizer